Early cholesterol treatment for acute coronary syndrome patients
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests whether starting a new cholesterol-lowering injection early helps people who recently had a heart-related event and a procedure to open blocked arteries. It aims to reduce future heart problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You were recently diagnosed with a non-ST-elevation acute coronary syndrome (a type of heart attack or unstable chest pain).
- You had a procedure called PCI (angioplasty) to open a blocked heart artery.
- Your LDL (bad) cholesterol level is between 1.8 and 3.4 mmol/L.
- You do not have severe heart failure, recent stroke, or serious liver or kidney disease.
- You are willing and able to receive injections and follow the study plan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving a new cholesterol-lowering drug, inclisiran, early during a hospital stay after a heart attack can help lower bad cholesterol (LDL) more effectively than usual care. It may reduce the risk of future heart problems.
This study tests whether giving a cholesterol-lowering injection (called a PCSK9 inhibitor) before a heart procedure to open blocked arteries can help people who are having a heart attack. The medicine may improve outcomes by lowering cholesterol quickly after the event.
This study tests whether a newer cholesterol-lowering injection, given early after a heart attack, helps keep the plaque in your arteries stable and reduces future risk. It compares the new medicine added to your usual statin treatment.
This study tests whether starting a cholesterol-lowering injection (a PCSK9 inhibitor) early after a heart attack can slow or shrink the buildup of plaque in other heart arteries that are not the one that was stented. If you have two other arteries with mild blockages, this treatment might help prevent future heart problems.
This study tests whether starting evolocumab (a cholesterol-lowering injection) soon after a heart attack helps prevent future heart problems. You'll receive the study drug or placebo for 52 weeks while your heart is monitored with imaging scans.
This trial tests whether giving a powerful cholesterol-lowering drug (PCSK9 inhibitor) very early after a heart attack can help prevent further heart problems. It is for people who have had a recent heart attack and have blockages in more than one heart artery.
Hear when a new Acute Coronary Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.